WEBULL

MicroPort CardioFlow Medtech Corporation's (HKG:2160) market cap surged HK$338m last week, public companies who have a lot riding on the company were rewarded

Simply Wall St · 03/20 00:37

Key Insights

  • MicroPort CardioFlow Medtech's significant public companies ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 2 shareholders own 54% of the company
  • Past performance of a company along with ownership data serve to give a strong idea about prospects for a business

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

To get a sense of who is truly in control of MicroPort CardioFlow Medtech Corporation (HKG:2160), it is important to understand the ownership structure of the business. With 46% stake, public companies possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, public companies were the biggest beneficiaries of last week’s 13% gain.

In the chart below, we zoom in on the different ownership groups of MicroPort CardioFlow Medtech.

View our latest analysis for MicroPort CardioFlow Medtech

ownership-breakdown
SEHK:2160 Ownership Breakdown March 20th 2025

What Does The Institutional Ownership Tell Us About MicroPort CardioFlow Medtech?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in MicroPort CardioFlow Medtech. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at MicroPort CardioFlow Medtech's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
SEHK:2160 Earnings and Revenue Growth March 20th 2025

MicroPort CardioFlow Medtech is not owned by hedge funds. MicroPort Scientific Corporation is currently the company's largest shareholder with 46% of shares outstanding. For context, the second largest shareholder holds about 7.5% of the shares outstanding, followed by an ownership of 2.8% by the third-largest shareholder.

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

Insider Ownership Of MicroPort CardioFlow Medtech

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our data suggests that insiders own under 1% of MicroPort CardioFlow Medtech Corporation in their own names. It seems the board members have no more than HK$4.0m worth of shares in the HK$3.0b company. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

General Public Ownership

With a 40% ownership, the general public, mostly comprising of individual investors, have some degree of sway over MicroPort CardioFlow Medtech. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

Private equity firms hold a 7.5% stake in MicroPort CardioFlow Medtech. This suggests they can be influential in key policy decisions. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

Public Company Ownership

Public companies currently own 46% of MicroPort CardioFlow Medtech stock. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For instance, we've identified 1 warning sign for MicroPort CardioFlow Medtech that you should be aware of.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.